About
Vaccine / Immunotherapy
Areas of Focus
Categories
Biologics & BiopharmaceuticalVaccineSeattle/Pacific Northwest
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
15
By Phase
PHASE1: 1PHASE2: 1
By Status
COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
Today
Hover over trial bars to see details
Recent Trials
NCT02234921Lead Sponsor
Pilot Study of DRibble Vaccine for Prostate Cancer Patients
PHASE1Completed
3 participants
Started: Oct 24, 2014 · Completed: Aug 15, 2018
NCT01909752Lead Sponsor
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
PHASE2Completed
12 participants
Started: Jul 31, 2013 · Completed: Apr 30, 2017
Locations (1)
Headquarters
Portland, OR, United States
Map
Loading map...